[EN] TETRAHYDRONAPHTHYL- PIPERAZINES AS 5-HT1B ANTAGONISTS, INVERSE AGONISTS AND PARTIAL AGONISTS<br/>[FR] TETRAHYDRONAPHTHYLPIPER- AZINES UTILISEES EN TANT QU'AGONISTES INVERSES, AGONISTES PARTIELS ET ANTAGONISTES DE 5-HT1B
申请人:PFIZER PROD INC
公开号:WO2005113527A1
公开(公告)日:2005-12-01
The present invention relates to novel tetrahydronaphthylpiperazines derivatives, that are compounds of the formula (I) wherein R1, R2 and R6 are as defined herein, X is CH2 or O, A is a group of the formula (G1, G2, G2a, G3, G4, G5 or G6) depicted below, and D is a group of the formula (D), wherein Y, W and Z are C or N and wherein R7 is as defined herein and their salts and compositions which include selective antagonists, inverse agonists and partial agonists of serotonin 1 (5-HT1) receptors. Compounds of the invention are useful in treating or preventing depression, anxiety, obsessive compulsive disorder (OCD) and other disorders for which a 5-HT1 agonist or antagonist is indicated.
Indolinone derivatives as protein kinase/phosphatase inhibitors
申请人:——
公开号:US20020052369A1
公开(公告)日:2002-05-02
The present invention relates to certain 2-indolinone compounds which modulate the activity of protein kinases (“PKs”) and phosphatases. The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
[EN] IAP INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉINE D'APOPTOSE
申请人:TETRALOGIC PHARM CORP
公开号:WO2010138496A1
公开(公告)日:2010-12-02
The present invention describes compounds, processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.
本发明描述了化合物、其制备方法、含有它们的药物组合物,以及它们在治疗中的应用。
Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
申请人:Tachdjian Catherine
公开号:US20050084506A1
公开(公告)日:2005-04-21
The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers,—savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.
[EN] NOVEL 4-(AZACYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS<br/>[FR] NOUVEAUX COMPOSÉS DE 4- (AZACYCLOALKYL) BENZENE-1, 3-DIOL UTILISÉS COMME INHIBITEURS DE LA TYROSINASE, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION EN MÉDICINE HUMAINE ET DANS LES COSMÉTIQUES
申请人:GALDERMA RES & DEV
公开号:WO2010063774A1
公开(公告)日:2010-06-10
The present invention relates to novel 4- (azacycloalkyl) benzene-1, 3-diol compounds corresponding to general formula (I) below: Formula (I) to the compositions containing same, to the process for the preparation thereof and to the use thereof in pharmaceutical or cosmetic compositions for use in the treatment or prevention of pigmentary disorders.